Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...
CAMBRIDGE, Mass., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results